Virus News and Research

Latest Virus News and Research

HIV prevalence among African Americans is ten times greater than the prevalence among whites

HIV prevalence among African Americans is ten times greater than the prevalence among whites. This racial disparity in HIV prevalence has persisted in the face of both governmental and private actions, involving many billions of dollars, to combat HIV.

6 Oct 2009

Drivers with Parkinson's disease at greater risk of crashes on foggy days

Drivers with mild to moderate Parkinson's disease may be at higher risk of crashes on foggy days and other times of low visibility. The research, involving a driving simulation test, is published in the October 6, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.

6 Oct 2009

U.N. officials highlight need for vaccine assistance to poor countries

U.N. officials on Sunday said that the H1N1 (swine flu) virus had arrived in poorer countries, highlighting a growing need for financial assistance and H1N1 vaccines for such regions, SAPA/News24.com reports.

6 Oct 2009

Research reveals that 52% Americans are not worried about H1N1 virus and its impact

As the first recipients of the H1N1 vaccine are vaccinated, more than half of Americans surveyed (52 percent) do not believe the H1N1 virus, or Swine Flu, will have a major impact in the United States compared to 44 percent who believe it will, according to the results of a new Deloitte Center for Health Solutions survey.

6 Oct 2009

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.

5 Oct 2009

Majority of Americans believe they are well-protected from H1N1

A new Harris poll, commissioned by SCA Tissue North America’s Tork® brand, reveals that 74 percent of U.S. adults say it is unlikely they will contract H1N1 this year.

5 Oct 2009

Preclinical study results of AVL-181 protease inhibitor presented

Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.

5 Oct 2009

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

Theraclone Sciences, Inc., a Seattle-based biotechnology company, and Zenyaku Kogyo Co., Ltd., a pharmaceutical company based in Tokyo, today announced that they have entered into a multi-year research and development agreement.

5 Oct 2009

NanoViricides completes a number of financing activities

NanoViricides, Inc. (the "Company"), announced today that it has completed a number of financing activities.

5 Oct 2009

Oral Cancer Foundation initiates program to donate VELscope screening systems

The Oral Cancer Foundation recently initiated a program of donating VELscope® Oral Cancer Screening Systems to free clinics and others located in, and helping communities with, underserved populations.

5 Oct 2009

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus (SynConTM) H1N1 influenza vaccine candidates achieved protective antibody responses against the novel pandemic influenza A/H1N1 (2009) in 100% of tested ferrets.

5 Oct 2009

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.

5 Oct 2009

American Lung Association kicks off its Faces of Influenza campaign in Miami

The American Lung Association of Florida-South Area is kicking off its 2009-2010 Faces of Influenza initiative by conducting a public influenza panel discussion to help Miami area residents understand the seriousness of seasonal influenza and the importance of annual vaccination. The meeting will address the latest flu statistics and benefits of vaccination, especially among high-risk groups.

3 Oct 2009

Bristol-Myers Squibb to present new data on BARACLUDE and other compounds at the AASLD 2009

New data on four Bristol-Myers Squibb Company (NYSE:BMY) compounds will be presented at the 60th annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston from October 30 to November 3.

3 Oct 2009

Misuse of aspirin might have caused high death rate during 1918-1919 influenza pandemic

The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high.

3 Oct 2009

Surgical masks nearly as effective as N95 respirators in protecting health care workers against influenza

Surgical masks appear to be no worse than, and nearly as effective as N95 respirators in preventing influenza in health care workers, according to a study released early online today by JAMA. The study was posted online ahead of print because of its public health implications. It will be published in the November 4 issue of JAMA.

3 Oct 2009

Surgical masks appear as effective as N95 respirators against influenza: Study

A McMaster University study has found that surgical masks appear to be as good as N95 respirators in protecting health-care workers against influenza.

3 Oct 2009

HHS distribute new flu-response guide for community and faith-based organizations

Officials from the U.S. Department of Health and Human Services (HHS) and the White House Office for Faith-based and Neighborhood Partnerships began distributing a new flu-response guide for community and faith-based organizations this week in an effort to reach out and educate Americans about the dangers of the new H1N1 and seasonal flu, and to reach populations who may not have access to this public health information in other ways.

3 Oct 2009

JBAIDS approved by the military for H1N1 virus detection tests

Idaho Technology’s Joint Biological Agent Identification and Diagnostic System (JBAIDS) has been approved by the military to run tests for the H1N1 virus. Deployed across the globe, including in Iraq and Afghanistan, by all four branches of the military, the JBAIDS instrument will be used to test military personnel and their families for Influenza A, swine flu A and H1 swine flu in less than an hour.

3 Oct 2009

Vaccinate children with H1N1 flu vaccine to control swine flu: UAB

The optimal way to control swine flu, the new H1N1 virus that emerged as a global threat in 2009, is to vaccinate children with the planned H1N1 flu vaccine, says the co-director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases.

3 Oct 2009

Virus News and Research

Latest Virus News and Research

HIV prevalence among African Americans is ten times greater than the prevalence among whites

Drivers with Parkinson's disease at greater risk of crashes on foggy days

U.N. officials highlight need for vaccine assistance to poor countries

Research reveals that 52% Americans are not worried about H1N1 virus and its impact

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

Majority of Americans believe they are well-protected from H1N1

Preclinical study results of AVL-181 protease inhibitor presented

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

NanoViricides completes a number of financing activities

Oral Cancer Foundation initiates program to donate VELscope screening systems

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

American Lung Association kicks off its Faces of Influenza campaign in Miami

Bristol-Myers Squibb to present new data on BARACLUDE and other compounds at the AASLD 2009

Misuse of aspirin might have caused high death rate during 1918-1919 influenza pandemic

Surgical masks nearly as effective as N95 respirators in protecting health care workers against influenza

Surgical masks appear as effective as N95 respirators against influenza: Study

HHS distribute new flu-response guide for community and faith-based organizations

JBAIDS approved by the military for H1N1 virus detection tests

Vaccinate children with H1N1 flu vaccine to control swine flu: UAB

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in